Ussing chambers for the study of nanoparticle permeability in the human jejunum
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-B-029-Tuesday
- By: LUNDQUIST, Patrik (Uppsala University, Pharmacy, Uppsala, Sweden)
- Co-author(s): Patrik Lundquist: Department of Pharmacy, Uppsala University, Uppsala, Sweden
Georgiy Khodus: Department of Pharmacy, Uppsala University, Uppsala, Sweden
Ivailo Simoff: Department of Pharmacy, Uppsala University, Uppsala, Sweden
Lungile Thwala: Dept. of Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Santiago de Compostela, Spain
Zhigao Niu: Dept. of Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Santiago de Compostela, Spain
Dominic-Luc Webb: Department of Medical Sciences, Gastroenterology/Hepatalogy, Uppsala University, Uppsala, Sweden
Per Hellström: Department of Medical Sciences, Gastroenterology/Hepatalogy, Uppsala University, Uppsala, Sweden
Magnus Sundbom: Department of Surgical Sciences, Upper Abdominal Surgery, Uppsala University, Uppsala, Sweden
Åsa Keita: Department of Clinical and Experimental Medicine (IKE) / Division of Clinical Sciences (KLINV), Linköping University, Linköping, Sweden
Noemi Csaba: Dept. of Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Santiago de Compostela, Spain
María José Alonso: Dept. of Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Santiago de Compostela, Spain
Mikael Wiren: Department of Clinical and Experimental Medicine (IKE) / Division of Clinical Sciences (KLINV), Linköping University, Linköping, Sweden
Johan Dabrosin Söderholm: Department of Clinical and Experimental Medicine (IKE) / Division of Clinical Sciences (KLINV), Linköping University, Linköping, Sweden
Per Artursson: Department of Pharmacy, Uppsala University, Uppsala, Sweden - Abstract:
Backgrounds
Oral delivery of peptide drugs and biopharmaceutics remains a challenge. A possible way to achieve improved bioavailability of such drugs after oral administration could be to encapsulate the molecules in a nanoparticle that protects them from the harsh environment of the gastrointestinal tract and aids their penetration of the.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023